Allworth Financial LP Biogen Inc. Transaction History

Allworth Financial LP

$16.1 Billion
Q3 2024

A detailed history of Allworth Financial LP transactions in Biogen Inc. stock. As of the latest transaction made, Allworth Financial LP holds 1,181 shares of BIIB stock, worth $179,760. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,181

Previous 1,046 12.91%

Holding current value

$179,760

Previous $242,000 5.79%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$189.07 - $236.8 $25,524 - $31,968	135 Added 12.91%	1,181 $228,000
Q2 2024 Jul 23, 2024	BUY	$190.52 - $236.72 $53,726 - $66,755	282 Added 36.91%	1,046 $242,000
Q1 2024 Apr 25, 2024	BUY	$212.02 - $267.71 $34,771 - $43,904	164 Added 27.33%	764 $164,000
Q4 2023 Jan 24, 2024	SELL	$222.59 - $267.94 $3,784 - $4,554	-17 Reduced 2.76%	600 $155,000
Q3 2023 Oct 31, 2023	BUY	$253.3 - $285.89 $10,385 - $11,721	41 Added 7.12%	617 $158,000
Q2 2023 Jul 18, 2023	BUY	$275.25 - $318.06 $825 - $954	3 Added 0.52%	576 $164,000
Q1 2023 Apr 18, 2023	SELL	$256.56 - $292.34 $3,078 - $3,508	-12 Reduced 2.05%	573 $159,000
Q4 2022 Jan 13, 2023	SELL	$252.44 - $306.72 $34,584 - $42,020	-137 Reduced 18.98%	585 $0
Q3 2022 Oct 18, 2022	BUY	$194.69 - $268.46 $7,592 - $10,469	39 Added 5.71%	722 $193,000
Q2 2022 Jul 13, 2022	BUY	$187.54 - $223.02 $3,750 - $4,460	20 Added 3.02%	683 $139,000
Q1 2022 Apr 22, 2022	SELL	$193.77 - $244.14 $19,764 - $24,902	-102 Reduced 13.33%	663 $140,000
Q4 2021 Jan 21, 2022	SELL	$223.92 - $287.77 $55,308 - $71,079	-247 Reduced 24.41%	765 $184,000
Q3 2021 Nov 02, 2021	BUY	$282.99 - $369.05 $144,324 - $188,215	510 Added 101.59%	1,012 $286,000
Q2 2021 Aug 02, 2021	SELL	$259.0 - $414.71 $48,951 - $78,380	-189 Reduced 27.35%	502 $174,000
Q2 2020 Jul 24, 2020	BUY	$258.66 - $342.55 $77,598 - $102,765	300 Added 76.73%	691 $185,000
Q1 2020 Apr 17, 2020	BUY	$268.85 - $341.04 $5,377 - $6,820	20 Added 5.39%	391 $124,000
Q4 2019 Jan 16, 2020	BUY	$220.06 - $304.07 $74,160 - $102,471	337 Added 991.18%	371 $110,000
Q2 2019 Jul 25, 2019	SELL	$219.29 - $241.72 $5,043 - $5,559	-23 Reduced 40.35%	34 $8,000
Q1 2019 May 07, 2019	SELL	$216.71 - $338.96 $23,621 - $36,946	-109 Reduced 65.66%	57 $13,000
Q4 2018 Feb 11, 2019	BUY	$278.5 - $352.75 $16,710 - $21,165	60 Added 56.6%	166 $50,000
Q3 2018 Oct 30, 2018	SELL	$293.51 - $383.83 $4,109 - $5,373	-14 Reduced 11.67%	106 $37,000
Q2 2018 Aug 08, 2018	BUY	$257.52 - $306.91 $3,347 - $3,989	13 Added 12.15%	120 $35,000
Q1 2018 May 02, 2018	SELL	$260.13 - $367.91 $260 - $367	-1 Reduced 0.93%	107 $29,000
Q4 2017 Feb 22, 2018	BUY	$307.64 - $344.58 $615 - $689	2 Added 1.89%	108 $34,000
Q2 2017 Aug 07, 2017	BUY	N/A	106	106 $29,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.

Account

Allworth Financial LP Biogen Inc. Transaction History